Dr. White on Omitting Radiation in Breast Cancer

Julia White, MD
Published: Monday, Sep 12, 2016



Julia White, MD, professor of Radiation Oncology, Ohio State University Comprehensive Cancer Center, discusses the omission of radiation therapy for patients with breast cancer.

Omitting radiation in this space requires finding a population of patients that has a low enough overall risk following lumpectomy, says White. The omission of radiation will leave patients with a slightly higher locoregional recurrence risk than if they had been radiated or had undergone a mastectomy.

The omission of radiation in younger patients with breast cancer. This is a bit harder, says White, because there are some subgroups of patients that can have quite high recurrence risks. Biologic selection criteria can be used along with the basic, clinical pathologic criteria to find a group of patients who may, indeed, have a slightly higher risk of local recurrence, but whose overall survival will not be significantly affected.


Julia White, MD, professor of Radiation Oncology, Ohio State University Comprehensive Cancer Center, discusses the omission of radiation therapy for patients with breast cancer.

Omitting radiation in this space requires finding a population of patients that has a low enough overall risk following lumpectomy, says White. The omission of radiation will leave patients with a slightly higher locoregional recurrence risk than if they had been radiated or had undergone a mastectomy.

The omission of radiation in younger patients with breast cancer. This is a bit harder, says White, because there are some subgroups of patients that can have quite high recurrence risks. Biologic selection criteria can be used along with the basic, clinical pathologic criteria to find a group of patients who may, indeed, have a slightly higher risk of local recurrence, but whose overall survival will not be significantly affected.

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Cancer Summaries and Commentaries™: Update from Chicago: Advances in the Treatment of Breast CancerJul 31, 20181.0
Community Practice Connections™: Medical Crossfire®: Translating Lessons Learned with PARP Inhibition to the Treatment of Breast Cancer—Expert Exchanges on Novel Strategies to Personalize CareAug 29, 20181.5
Publication Bottom Border
Border Publication
x